Neurofilaments as a plasma biomarker for ICU-acquired weakness: An observational pilot study

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Wieske, Luuk ^a,b   Witteveen, Esther ^a,b   Petzold, Axel ^c,d   Verhamme, Camiel ^b   Schultz, Marcus J ^a,b   van Schaik, Ivo N ^b   Horn, Janneke ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGED; BLOOD; COHORT ANALYSIS; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTERMEDIATE FILAMENT; MALE; METABOLISM; MIDDLE AGED; MUSCLE WEAKNESS; PILOT STUDY; PROSPECTIVE STUDY;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTERMEDIATE FILAMENTS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84894269383     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13699     Document Type: Article

References (29)

1. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011, 10:931-941. 10.1016/S1474-4422(11)70178-8, 21939902.
2. Stevens RD, Marshall SA, Cornblath DR, Hoke A, Needham DM, De Jonghe B, Ali NA, Sharshar T. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009, 37:S299-S308.
3. Hough CL, Lieu BK, Caldwell ES. Manual muscle strength testing of critically ill patients: feasibility and interobserver agreement. Crit Care 2011, 15:R43. 10.1186/cc10005, 3221972, 21276225.
4. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009, 373:1874-1882. 10.1016/S0140-6736(09)60658-9, 19446324.
5. Petzold A, Keir G, Green AJE, Giovannoni G, Thompson EJ. A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods 2003, 278:179-190. 10.1016/S0022-1759(03)00189-3, 12957406.
6. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG, Standards for Reporting of Diagnostic Accuracy The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003, 138:W1-W12. 10.7326/0003-4819-138-1-200301070-00012-w1, 12513067, Standards for Reporting of Diagnostic Accuracy.
7. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19:604-607. 10.1161/01.STR.19.5.604, 3363593.
8. Hermans G, Clerckx B, Vanhullebusch T, Segers J, Vanpee G, Robbeets C, Casaer MP, Wouters P, Gosselink R, Van den Berghe G. Interobserver agreement of medical research council sum-score and handgrip strength in the intensive care unit. Muscle Nerve 2011, 45:18-25.
9. Connolly BA, Jones GD, Curtis AA, Murphy PB, Douiri A, Hopkinson NS, Polkey MI, Moxham J, Hart N. Clinical predictive value of manual muscle strength testing during critical illness: an observational cohort study. Crit Care 2013, 17:R229. 10.1186/cc13052, 24112540.
10. Petzold A, Shaw G. Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain. J Immunol Methods 2007, 319:34-40. 10.1016/j.jim.2006.09.021, 17140597.
11. Petzold A, Verwey NA, van Uffelen K, Blankenstein MA, Teunissen C. Batch prepared protein standards for cerebrospinal fluid (CSF) biomarkers for neurodegeneration. J Neurosci Methods 2010, 193:296-299. 10.1016/j.jneumeth.2010.08.028, 20832428.
12. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874. 10.1097/00003246-199206000-00025, 1597042.
13. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005, 365:63-78. 10.1016/S0140-6736(04)17667-8, 15639681.
14. Sakr Y, Lobo SM, Moreno R, Gerlach H, Ranieri VM, Michalopoulos A, Vincent JL, SOAP (Sepsis Occurrence in Acutely ill Patients) Investigators Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome. Crit Care 2012, 16:R222. 10.1186/cc11868, 3672601, 23158219, SOAP (Sepsis Occurrence in Acutely ill Patients) Investigators.
15. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Müller M. pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinformatics 2011, 12:77. 10.1186/1471-2105-12-77, 3068975, 21414208.
16. Batt J, dos Santos CC, Cameron JI, Herridge MS. Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med 2013, 187:238-246. 10.1164/rccm.201205-0954SO, 23204256.
17. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 2005, 233:183-198. 10.1016/j.jns.2005.03.015, 15896809.
18. Sellner J, Patel A, Dassan P, Brown MM, Petzold A. Hyperacute detection of neurofilament heavy chain in serum following stroke: a transient sign. Neurochem Res 2011, 36:2287-2291. 10.1007/s11064-011-0553-8, 21792676.
19. Boylan KB, Glass JD, Crook JE, Yang C, Thomas CS, Desaro P, Johnston A, Overstreet K, Kelly C, Polak M, Shaw G. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2013, 84:467-472. 10.1136/jnnp-2012-303768, 23117489.
20. Hayakawa K, Okazaki R, Ishii K, Ueno T, Izawa N, Tanaka Y, Toyooka S, Matsuoka N, Morioka K, Ohori Y, Nakamura K, Akai M, Tobimatsu Y, Hamabe Y, Ogata T. Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study. Spinal Cord 2012, 50:493-496. 10.1038/sc.2011.184, 22270191.
21. Rundgren M, Friberg H, Cronberg T, Romner B, Petzold A. Serial soluble neurofilamnet heavy chain in plasma as a marker of brain injury after cardiac arrest. Crit Care 2012, 16:R45. 10.1186/cc11244, 3681370, 22410303.
22. Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Françoise G. The neuropathology of septic shock. Brain Pathol 2004, 14:21-33.
23. Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve 2005, 32:140-163. 10.1002/mus.20304, 15825186.
24. Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL, Ortiz-Leyba C, Jiménez-Jiménez FJ, Barrero-Almodóvar A, Garnacho-Montero MC, Moyano-Del-Estad MR. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001, 27:1288-1296. 10.1007/s001340101009, 11511941.
25. Weber-Carstens S, Koch S, Spuler S, Spies CD, Bubser F, Wernecke KD, Deja M. Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med 2009, 37:2632-2637. 10.1097/CCM.0b013e3181a92f28, 19623045.
26. Grimm A, Teschner U, Porzelius C, Ludewig K, Zielske J, Witte OW, Brunkhorst FM, Axer H. Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis. Crit Care 2013, 17:R227. 10.1186/cc13050, 24499688.
27. Koch S, Spuler S, Deja M, Bierbrauer J, Dimroth A, Behse F, Spies CD, Wernecke KD, Weber-Carstens S. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiatry 2011, 82:287-293. 10.1136/jnnp.2009.192997, 20802220.
28. Guarneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry 2008, 79:838-841. 10.1136/jnnp.2007.142430, 18339730.
29. Petzold A, Altintas A, Andreoni L, Bartos A, Berthele A, Blankenstein MA, Buee L, Castellazzi M, Cepok S, Comabella M, Constantinescu CS, Deisenhammer F, Deniz G, Erten G, Espiño M, Fainardi E, Franciotta D, Freedman MS, Giedraitis V, Gilhus NE, Giovannoni G, Glabinski A, Grieb P, Hartung HP, Hemmer B, Herukka SK, Hintzen R, Ingelsson M, Jackson S, Jacobsen S, et al. Neurofilament ELISA validation. J Immunol Methods 2010, 352:23-31. 10.1016/j.jim.2009.09.014, 19857497.